These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35076886)

  • 21. Prolonged QT Interval in Patients Receiving Psychotropic Medications.
    Swenson RS; Murphy-Ende K
    J Am Psychiatr Nurses Assoc; 2020; 26(4):344-353. PubMed ID: 31509051
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series.
    Birnbaum CS; Cohen LS; Bailey JW; Grush LR; Robertson LM; Stowe ZN
    Pediatrics; 1999 Jul; 104(1):e11. PubMed ID: 10390297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity, psychiatric status, and psychiatric medications.
    Berkowitz RI; Fabricatore AN
    Psychiatr Clin North Am; 2005 Mar; 28(1):39-54, vii-viii. PubMed ID: 15733610
    [No Abstract]   [Full Text] [Related]  

  • 24. Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment.
    Schlienz NJ; Huhn AS; Speed TJ; Sweeney MM; Antoine DG
    Int Rev Psychiatry; 2018 Oct; 30(5):147-154. PubMed ID: 30398080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiometabolic effects of psychotropic medications.
    Abosi O; Lopes S; Schmitz S; Fiedorowicz JG
    Horm Mol Biol Clin Investig; 2018 Jan; 36(1):. PubMed ID: 29320364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotropic medication in chronic spinal disorders.
    Polatin PB; Dersh J
    Spine J; 2004; 4(4):436-50. PubMed ID: 15246306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Why getting fat, Doc?' Weight gain and psychotropic medications.
    Malhi GS; Mitchell PB; Caterson I
    Aust N Z J Psychiatry; 2001 Jun; 35(3):315-21. PubMed ID: 11437804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Serum Concentration of Antidepressants After Bariatric Surgery and Recommendations for Postbariatric Surgery Antidepressant Therapy.
    Maass D; Cumming D; Raza H; Liao T; Chung J; Pao M
    J Acad Consult Liaison Psychiatry; 2024; 65(3):261-270. PubMed ID: 38220143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons of the costs of psychotropic medications: an update.
    Jurman RJ; Davis JM
    Psychiatr Med; 1991; 9(2):349-59. PubMed ID: 1677482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.
    Yonkers KA; Kando JC; Cole JO; Blumenthal S
    Am J Psychiatry; 1992 May; 149(5):587-95. PubMed ID: 1575248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight gain associated with psychotropic drugs.
    Brady KT
    South Med J; 1989 May; 82(5):611-7. PubMed ID: 2566204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in pharmacologic management of the hospitalized patient with psychiatric comorbidity.
    Ward M; Schwartz A
    J Hosp Med; 2013 Sep; 8(9):523-9. PubMed ID: 23913579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
    Vandenberghe F; Gholam-Rezaee M; Saigí-Morgui N; Delacrétaz A; Choong E; Solida-Tozzi A; Kolly S; Thonney J; Gallo SF; Hedjal A; Ambresin AE; von Gunten A; Conus P; Eap CB
    J Clin Psychiatry; 2015 Nov; 76(11):e1417-23. PubMed ID: 26646038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Factors Associated With Psychiatric Medication Use in Bariatric Surgery Candidates.
    Hawkins M; Lee A; Leung S; Hawa R; Wnuk S; Yanofsky R; Sockalingam S
    Psychosomatics; 2019; 60(5):449-457. PubMed ID: 30558795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.
    Ohayon MM; Lader MH
    J Clin Psychiatry; 2002 Sep; 63(9):817-25. PubMed ID: 12363124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.
    Blay SL; Fillenbaum GG; Pitta JC; Peluso ET
    Int Clin Psychopharmacol; 2014 May; 29(3):157-65. PubMed ID: 24172159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.
    Gracious BL; Bhatt R; Potter C
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):602-10. PubMed ID: 26447642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity of psychotropic drugs in patients with COVID-19: A systematic review.
    Sabe M; Dorsaz O; Huguelet P; Kaiser S
    Gen Hosp Psychiatry; 2021; 70():1-9. PubMed ID: 33631694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.